However, Estrada\Acosta et al. the articles determined and independently extracted the info. Main results Only 1 RCT?of the immunomodulatory or immunosuppressive agent continues to be
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor